Future research directions will pay more attention to the development of personalized intervention strategies, the exploration of new therapeutic targets, and the integration of interdisciplinary research, especially the treatment strategies based on bile acid metabolic pathways and signaling pathways (such as TGR5 and FXR), which are expected to provide new ideas and methods for the treatment of metabolic diseases. Here, GPBAR1 is linked to metabolic disease.